Drugs And Decontrol

The pharma pricing policy benefits foreign firms more than Indian companies. A report on who gains, who loses

After endless delays, the much-awaited drug policy was finally approved by the government last week.

The pharmaceutical industry had been lobbying hard for further cuts in controls. For one, they point out, the prices of many controlled drugs have been falling steadily over the years.

In many cases, a drug